Overview of Mainstream Perp DEXs: Trading volumes on various platforms have generally declined, with Hyperliquid's trading volume dropping approximately 15.5%

MarsBitNews · 2026-02-27T11:26:58+00:00

As of February 27, trading volume on mainstream Perp DEXs generally declined, with Hyperliquid leading at $6.03 billion in trading volume, followed closely by Aster. The trading volumes are $2.46 billion and $2.27 billion respectively. The overall market performance is sluggish, and the open interest has also decreased.

MarsBitNews

2026-02-27 11:26:58

Abstract generation in progress

Mars Finance reports that on February 27, according to DefiLlama data, trading volumes across major Perp DEXs have generally declined over the past 24 hours. Hyperliquid’s trading volume decreased by approximately 15.5% compared to yesterday, while Aster has maintained relatively high trading volumes recently, ranking second. The current trading volume rankings for major Perp DEXs are as follows: Hyperliquid with approximately $6.03 billion in 24-hour trading volume, approximately $4.24 billion in TVL, and about $5.48 billion in open interest; Aster with approximately $2.46 billion in 24-hour trading volume, approximately $1.06 billion in TVL, and about $1.87 billion in open interest; EdgeX with approximately $2.27 billion in 24-hour trading volume, approximately $182 million in TVL, and about $104 million in open interest; Lighter with approximately $2.08 billion in 24-hour trading volume, approximately $870 million in TVL, and about $712 million in open interest; Grvt with approximately $1.27 billion in 24-hour trading volume, approximately $95.76 million in TVL, and about $408 million in open interest; Pacifica with approximately $718 million in 24-hour trading volume, approximately $36.23 million in TVL, and about $61.6 million in open interest.

HYPE-3.56%

ASTER-0.91%

LIT-5.71%

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.